A research team at Academia Sinica has developed a key reagent for a pioneering rapid screening test for the COVID-19 coronavirus disease and the technology has been transferred to seven companies, one or two of which will be chosen for possible mass production, James Liao (廖俊智), president of Taiwan's most prestigious research institution, said Thursday.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Society
Magnitude 6.1 earthquake jolts eastern Taiwan
04/27/2024 02:54 AM - Politics
A discussion with Cosette Wu, the woman behind the Harvard speech disruption
04/26/2024 11:25 PM - Society
32 indicted in NT$800 million crypto fraud case
04/26/2024 10:50 PM - Business
Taiwan, U.S. to hold new round of trade talks in Taipei next week: Office
04/26/2024 10:18 PM - Culture
Budapest picked as 2024 Taipei Film Festival's 'City in Focus'
04/26/2024 10:00 PM